{"id":252640,"date":"2024-12-07T14:54:03","date_gmt":"2024-12-07T13:54:03","guid":{"rendered":"https:\/\/r3i.org\/folletos\/"},"modified":"2025-10-24T16:42:26","modified_gmt":"2025-10-24T14:42:26","slug":"folletos","status":"publish","type":"page","link":"https:\/\/r3i.org\/es\/folletos\/","title":{"rendered":"Folletos"},"content":{"rendered":"

[et_pb_section fb_built=\u00bb1″ admin_label=\u00bbHeader\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bb8a9a809c-7a33-46fa-a9c3-6cbb2909b12a\u00bb background_image=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2024\/12\/Design-sans-titre.png\u00bb parallax=\u00bbon\u00bb custom_padding=\u00bb1vw||1vw||true|false\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22background_color_gradient_stops%22%93}\u00bb][et_pb_row column_structure=\u00bb2_3,1_3″ _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb2_3″ _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbFolletos\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bba97d2c6e-7b99-4859-b03c-bd1a8625b1d7″ title_font=\u00bbPoppins||||||||\u00bb title_text_align=\u00bbleft\u00bb title_text_color=\u00bb#FFFFFF\u00bb title_font_size=\u00bb65px\u00bb custom_margin=\u00bb||10px||false|false\u00bb custom_margin_tablet=\u00bb||10px||false|false\u00bb custom_margin_phone=\u00bb15px||-101px||false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb text_shadow_style=\u00bbpreset1″ global_colors_info=\u00bb{}\u00bb][\/et_pb_heading][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ admin_label=\u00bbHeader\u00bb _builder_version=\u00bb4.22.0″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb4px||0px||false|false\u00bb locked=\u00bboff\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.22.0″ _module_preset=\u00bbdefault\u00bb max_width=\u00bb1280px\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.22.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bb9f6e647e-3529-4a8c-8487-74b921fe9a70″ header_4_text_color=\u00bbgcid-primary-color\u00bb header_4_font_size=\u00bb27px\u00bb text_orientation=\u00bbcenter\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22header_4_text_color%22%93}\u00bb]<\/p>\n

Folletos de R3i<\/h4>\n

[\/et_pb_text][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bb8f7b93dd-8128-4a3b-9c64-f623856d74f1″ text_orientation=\u00bbcenter\u00bb max_width=\u00bb800px\u00bb module_alignment=\u00bbcenter\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

Los folletos R3i proporcionan valiosos conocimientos e informaci\u00f3n basada en pruebas para educar a los profesionales de la salud sobre el riesgo vascular residual y las terapias emergentes, como los tratamientos dirigidos a la PCSK9 y los agonistas SPPARM\u03b1. Mediante la difusi\u00f3n de los resultados de la investigaci\u00f3n, los resultados de los ensayos cl\u00ednicos y la opinion de los expertos, R3i pretende mejorar la comprensi\u00f3n y promover la adopci\u00f3n de estrategias innovadoras en el tratamiento de los pacientes de alto riesgo.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

\u00daltimo Folleto<\/h2>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_2,1_2″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2025\/09\/Capture-decran-2025-09-26-182243.png\u00bb title_text=\u00bbCapture d\u2019\u00e9cran 2025-09-26 182243″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

Retinopat\u00eda diab\u00e9tica
como afecci\u00f3n
microvascular residual<\/h3>\n

[\/et_pb_text][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_6_text_color=\u00bb#000000″ global_colors_info=\u00bb{}\u00bb]<\/p>\n

Yohei Tomita, MD. Ph.D.<\/h6>\n

[\/et_pb_text][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

Este folleto, un proyecto de la Iniciativa de Reducci\u00f3n del Riesgo
Residual (R3i), est\u00e1 dise\u00f1ado para aumentar significativamente
la conciencia y la comprensi\u00f3n de la retinopat\u00eda diab\u00e9tica
(RD) como una condici\u00f3n microvascular residual persistente
y a menudo pasada por alto. La RD sigue siendo una de las
principales causas de p\u00e9rdida de visi\u00f3n prevenible, y nuestra
iniciativa est\u00e1 dedicada a brindar a los profesionales de la salud
los conocimientos necesarios no solo para identificar y manejar
de manera efectiva esta compleja enfermedad, sino tambi\u00e9n para
reducir en \u00faltima instancia su devastador impacto en la vida de
los pacientes. Creemos firmemente que un enfoque proactivo
y multifac\u00e9tico para la reducci\u00f3n de riesgos es absolutamente
esencial para preservar la visi\u00f3n y mejorar dr\u00e1sticamente los
resultados de las personas que viven con diabetes.
El contenido presentado en este recurso proporciona una
descripci\u00f3n general completa de los aspectos clave de la RD,
cubriendo sistem\u00e1ticamente todo, desde su fisiopatolog\u00eda
subyacente y clasificaci\u00f3n seg\u00fan la gravedad, hasta los factores
de riesgo cr\u00edticos que contribuyen a su progresi\u00f3n. El folleto
tambi\u00e9n ofrece una exploraci\u00f3n detallada de las mejores pr\u00e1cticas
actuales en metodolog\u00edas de diagn\u00f3stico y destaca estrategias
de tratamiento establecidas e innovadoras para el manejo de
la RD en varias etapas. Su objetivo es ofrecer una perspectiva
actual sobre la enfermedad, mostrando tanto conocimientos
consolidados como tendencias emergentes y avances
prometedores en el campo. Si bien se han logrado avances
sustanciales en el tratamiento de la RD, es imperativo reconocer
que la enfermedad sigue siendo compleja y desafiante, y requiere
una vigilancia constante y un compromiso con el aprendizaje
continuo y la mejora en la atenci\u00f3n al paciente.<\/p>\n

[\/et_pb_text][et_pb_button button_url=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2025\/09\/Spanish-DR-Book-2025-v02-FINAL_ES.pdf\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbDescargar folleto (PDF)\u00bb button_alignment=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb||4px|0px|false|false\u00bb custom_margin_tablet=\u00bb|||0px|false|false\u00bb custom_margin_phone=\u00bb|||0px|false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ admin_label=\u00bbCouse Categories\u00bb _builder_version=\u00bb4.22.0″ _module_preset=\u00bbdefault\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

Otros Folletos<\/h2>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb max_width=\u00bb1280px\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbRGBA(255,255,255,0)\u00bb custom_padding=\u00bb40px|30px|40px|30px|true|true\u00bb custom_padding_tablet=\u00bb40px|30px|40px|30px|true|true\u00bb custom_padding_phone=\u00bb30px|20px|30px|20px|true|true\u00bb custom_padding_last_edited=\u00bbon|phone\u00bb link_option_url=\u00bb#\u00bb border_radii=\u00bbon|10px|10px|10px|10px\u00bb border_width_all=\u00bb2px\u00bb border_color_all=\u00bb#000000″ global_colors_info=\u00bb{%22gcid-610d28dd-eb23-4fae-b502-62f0b357c8fd%22:%91%22background_color%22%93,%22gcid-834db33f-400f-4068-917d-2de62be3172e%22:%91%22background_color__hover%22%93}\u00bb background__hover_enabled=\u00bbon|hover\u00bb background_color__hover=\u00bb#e0e0e0″ background_enable_color__hover=\u00bbon\u00bb border_color_all__hover=\u00bbRGBA(255,255,255,0)\u00bb border_color_all__hover_enabled=\u00bbon|hover\u00bb][et_pb_image src=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2025\/04\/Screenshot-2025-04-06-at-19.22.37.png\u00bb title_text=\u00bbScreenshot 2025-04-06 at 19.22.37″ align=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb max_width=\u00bb64px\u00bb max_height=\u00bb64px\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbeb254ae5-cb97-4f48-8335-7aee66a763fe\u00bb header_text_align=\u00bbcenter\u00bb header_4_text_color=\u00bbgcid-primary-color\u00bb text_orientation=\u00bbcenter\u00bb custom_margin=\u00bb||0px||false|false\u00bb custom_margin_tablet=\u00bb||0px||false|false\u00bb custom_margin_phone=\u00bb||0px||false|false\u00bb custom_margin_last_edited=\u00bbon|desktop\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22header_4_text_color%22%93}\u00bb]<\/p>\n

Esteatohepatitis asociada con la disfunci\u00f3n metab\u00f3lica (MASH)<\/h4>\n

 <\/p>\n

 <\/p>\n

[\/et_pb_text][et_pb_text _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bblink_option_url\u00bb _module_preset=\u00bbdefault\u00bb header_text_align=\u00bbcenter\u00bb module_alignment=\u00bbcenter\u00bb link_option_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1NTMyNSJ9fQ==@\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

M\u00e1s informaci\u00f3n…<\/span><\/p>\n

[\/et_pb_text][et_pb_button button_url=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2025\/04\/MASH-Booklet-v03_HR-ES.pdf\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbDescargar folleto (PDF)\u00bb button_alignment=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb||4px|0px|false|false\u00bb custom_margin_tablet=\u00bb|||0px|false|false\u00bb custom_margin_phone=\u00bb|||0px|false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_button][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbRGBA(255,255,255,0)\u00bb custom_padding=\u00bb40px|30px|40px|30px|true|true\u00bb custom_padding_tablet=\u00bb40px|30px|40px|30px|true|true\u00bb custom_padding_phone=\u00bb30px|20px|30px|20px|true|true\u00bb custom_padding_last_edited=\u00bbon|phone\u00bb link_option_url=\u00bb#\u00bb border_radii=\u00bbon|10px|10px|10px|10px\u00bb border_width_all=\u00bb2px\u00bb border_color_all=\u00bb#000000″ global_colors_info=\u00bb{%22gcid-610d28dd-eb23-4fae-b502-62f0b357c8fd%22:%91%22background_color%22%93,%22gcid-834db33f-400f-4068-917d-2de62be3172e%22:%91%22background_color__hover%22%93}\u00bb background__hover_enabled=\u00bbon|hover\u00bb background_color__hover=\u00bb#e0e0e0″ background_enable_color__hover=\u00bbon\u00bb border_color_all__hover=\u00bbRGBA(255,255,255,0)\u00bb border_color_all__hover_enabled=\u00bbon|hover\u00bb][et_pb_image src=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2024\/12\/Screenshot-2024-12-16-at-23.12.25.png\u00bb title_text=\u00bbCaptura de pantalla 2024-12-16 a las 23.12.25″ align=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb max_width=\u00bb64px\u00bb max_height=\u00bb64px\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbeb254ae5-cb97-4f48-8335-7aee66a763fe\u00bb header_text_align=\u00bbcenter\u00bb header_4_text_color=\u00bbgcid-primary-color\u00bb text_orientation=\u00bbcenter\u00bb custom_margin=\u00bb||0px||false|false\u00bb custom_margin_tablet=\u00bb||0px||false|false\u00bb custom_margin_phone=\u00bb||0px||false|false\u00bb custom_margin_last_edited=\u00bbon|desktop\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22header_4_text_color%22%93}\u00bb]<\/p>\n

La PCSK9 como diana terap\u00e9utica:<\/span><\/h4>\n

Perspectivas de los ensayos cl\u00ednicos<\/span><\/h4>\n

[\/et_pb_text][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_text_align=\u00bbcenter\u00bb module_alignment=\u00bbcenter\u00bb link_option_url=\u00bbhttps:\/\/r3i.org\/es\/folleto-la-pcsk9-como-diana-terapeutica\/\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

M\u00e1s informaci\u00f3n…<\/span><\/p>\n

[\/et_pb_text][et_pb_button button_url=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2025\/02\/PCSK9-Therapeutic-Target-booklet_ES.pdf\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbDescargar folleto (PDF)\u00bb button_alignment=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb||4px|0px|false|false\u00bb custom_margin_tablet=\u00bb|||0px|false|false\u00bb custom_margin_phone=\u00bb|||0px|false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_button][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbRGBA(255,255,255,0)\u00bb custom_padding=\u00bb40px|30px|40px|30px|true|true\u00bb custom_padding_tablet=\u00bb40px|30px|40px|30px|true|true\u00bb custom_padding_phone=\u00bb30px|20px|30px|20px|true|true\u00bb custom_padding_last_edited=\u00bbon|phone\u00bb link_option_url=\u00bb#\u00bb border_radii=\u00bbon|10px|10px|10px|10px\u00bb border_width_all=\u00bb2px\u00bb border_color_all=\u00bb#000000″ global_colors_info=\u00bb{%22gcid-610d28dd-eb23-4fae-b502-62f0b357c8fd%22:%91%22background_color%22%93,%22gcid-834db33f-400f-4068-917d-2de62be3172e%22:%91%22background_color__hover%22%93}\u00bb background__hover_enabled=\u00bbon|hover\u00bb background_color__hover=\u00bb#e0e0e0″ background_enable_color__hover=\u00bbon\u00bb border_color_all__hover=\u00bbRGBA(255,255,255,0)\u00bb border_color_all__hover_enabled=\u00bbon|hover\u00bb][et_pb_image src=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2024\/12\/Screenshot-2024-12-16-at-23.19.51.png\u00bb title_text=\u00bbCaptura de pantalla 2024-12-16 a las 23.19.51″ align=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb max_width=\u00bb64px\u00bb max_height=\u00bb64px\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbeb254ae5-cb97-4f48-8335-7aee66a763fe\u00bb header_text_align=\u00bbcenter\u00bb header_4_text_color=\u00bbgcid-primary-color\u00bb text_orientation=\u00bbcenter\u00bb custom_margin=\u00bb||||false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22header_4_text_color%22%93}\u00bb]<\/p>\n

Lipoprote\u00ednas ricas en triglic\u00e9ridos y<\/span><\/h4>\n

ateroscler\u00f3tica <\/span>enfermedad cardiovascular<\/span><\/h4>\n

[\/et_pb_text][et_pb_text _builder_version=\u00bb4.27.4″ _dynamic_attributes=\u00bblink_option_url\u00bb _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb-24px||24px||false|false\u00bb link_option_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1MjY0MyJ9fQ==@\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

M\u00e1s informaci\u00f3n…<\/span><\/p>\n

[\/et_pb_text][et_pb_button button_url=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2025\/02\/TG-booklet-2021-ES.pdf\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbDescargar folleto (PDF)\u00bb button_alignment=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb|||0px|false|false\u00bb custom_margin_tablet=\u00bb|||0px|false|false\u00bb custom_margin_phone=\u00bb|||0px|false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb max_width=\u00bb1280px\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbRGBA(255,255,255,0)\u00bb custom_padding=\u00bb40px|30px|40px|30px|true|true\u00bb custom_padding_tablet=\u00bb40px|30px|40px|30px|true|true\u00bb custom_padding_phone=\u00bb30px|20px|30px|20px|true|true\u00bb custom_padding_last_edited=\u00bbon|phone\u00bb link_option_url=\u00bb#\u00bb border_radii=\u00bbon|10px|10px|10px|10px\u00bb border_width_all=\u00bb2px\u00bb border_color_all=\u00bb#000000″ global_colors_info=\u00bb{%22gcid-610d28dd-eb23-4fae-b502-62f0b357c8fd%22:%91%22background_color%22%93,%22gcid-834db33f-400f-4068-917d-2de62be3172e%22:%91%22background_color__hover%22%93}\u00bb background__hover_enabled=\u00bbon|hover\u00bb background_color__hover=\u00bb#e0e0e0″ background_enable_color__hover=\u00bbon\u00bb border_color_all__hover=\u00bbRGBA(255,255,255,0)\u00bb border_color_all__hover_enabled=\u00bbon|hover\u00bb][et_pb_image src=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2024\/12\/Screenshot-2024-12-16-at-23.32.04.png\u00bb title_text=\u00bbCaptura de pantalla 2024-12-16 a las 23.32.04″ align=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb max_width=\u00bb64px\u00bb max_height=\u00bb64px\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbeb254ae5-cb97-4f48-8335-7aee66a763fe\u00bb header_4_text_color=\u00bbgcid-primary-color\u00bb text_orientation=\u00bbcenter\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22header_4_text_color%22%93}\u00bb]<\/p>\n

Diferenciar SPPARM\u03b1 y fibratos (agonistas PPAR\u03b1)<\/span><\/h4>\n

[\/et_pb_text][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb link_option_url=\u00bbhttps:\/\/r3i.org\/es\/folleto-diferenciacion-entre-spparm%ce%b1-y-fibratos-agonistas-ppar%ce%b1\/\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

M\u00e1s informaci\u00f3n…<\/span><\/p>\n

[\/et_pb_text][et_pb_button button_url=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2025\/02\/Differentiating-SPPARM-Booklet-spanish.pdf\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbDescargar folleto (PDF)\u00bb button_alignment=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb|||0px|false|false\u00bb custom_margin_tablet=\u00bb|||0px|false|false\u00bb custom_margin_phone=\u00bb|||0px|false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_button][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbRGBA(255,255,255,0)\u00bb custom_padding=\u00bb40px|30px|40px|30px|true|true\u00bb custom_padding_tablet=\u00bb40px|30px|40px|30px|true|true\u00bb custom_padding_phone=\u00bb30px|20px|30px|20px|true|true\u00bb custom_padding_last_edited=\u00bbon|phone\u00bb link_option_url=\u00bb#\u00bb border_radii=\u00bbon|10px|10px|10px|10px\u00bb border_width_all=\u00bb2px\u00bb border_color_all=\u00bb#000000″ global_colors_info=\u00bb{%22gcid-610d28dd-eb23-4fae-b502-62f0b357c8fd%22:%91%22background_color%22%93,%22gcid-834db33f-400f-4068-917d-2de62be3172e%22:%91%22background_color__hover%22%93}\u00bb background__hover_enabled=\u00bbon|hover\u00bb background_color__hover=\u00bb#e0e0e0″ background_enable_color__hover=\u00bbon\u00bb border_color_all__hover=\u00bbRGBA(255,255,255,0)\u00bb border_color_all__hover_enabled=\u00bbon|hover\u00bb][et_pb_image src=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2024\/12\/Screenshot-2024-12-16-at-23.33.33.png\u00bb title_text=\u00bbCaptura de pantalla 2024-12-16 a las 23.33.33″ align=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb max_width=\u00bb64px\u00bb max_height=\u00bb64px\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbeb254ae5-cb97-4f48-8335-7aee66a763fe\u00bb header_4_text_color=\u00bbgcid-primary-color\u00bb text_orientation=\u00bbcenter\u00bb custom_margin=\u00bb-9px||||false|false\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22header_4_text_color%22%93}\u00bb]<\/p>\n

SPPARM\u03b1 en la encrucijada de la obesidad, la diabetes y las enfermedades cardiovasculares (2\u00aa edici\u00f3n)<\/span><\/h4>\n

[\/et_pb_text][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb-38px||||false|false\u00bb link_option_url=\u00bbhttps:\/\/r3i.org\/es\/folleto-ssparm%ce%b1-en-la-encrucijada-de-la-obesidad-la-diabetes-y-las-enfermedades-cardiovasculares-segunda-edicion\/\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

M\u00e1s informaci\u00f3n…<\/span><\/p>\n

[\/et_pb_text][et_pb_button button_url=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2024\/12\/SPPARM_Booklet-_v2.pdf\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbDescargar folleto (PDF)\u00bb button_alignment=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb|||0px|false|false\u00bb custom_margin_tablet=\u00bb|||0px|false|false\u00bb custom_margin_phone=\u00bb|||0px|false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_button][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbRGBA(255,255,255,0)\u00bb custom_padding=\u00bb40px|30px|40px|30px|true|true\u00bb custom_padding_tablet=\u00bb40px|30px|40px|30px|true|true\u00bb custom_padding_phone=\u00bb30px|20px|30px|20px|true|true\u00bb custom_padding_last_edited=\u00bbon|phone\u00bb link_option_url=\u00bb#\u00bb border_radii=\u00bbon|10px|10px|10px|10px\u00bb border_width_all=\u00bb2px\u00bb border_color_all=\u00bb#000000″ global_colors_info=\u00bb{%22gcid-610d28dd-eb23-4fae-b502-62f0b357c8fd%22:%91%22background_color%22%93,%22gcid-834db33f-400f-4068-917d-2de62be3172e%22:%91%22background_color__hover%22%93}\u00bb background__hover_enabled=\u00bbon|hover\u00bb background_color__hover=\u00bb#e0e0e0″ background_enable_color__hover=\u00bbon\u00bb border_color_all__hover=\u00bbRGBA(255,255,255,0)\u00bb border_color_all__hover_enabled=\u00bbon|hover\u00bb][et_pb_image src=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2024\/12\/Screenshot-2024-12-16-at-23.44.28.png\u00bb title_text=\u00bbCaptura de pantalla 2024-12-16 a las 23.44.28″ align=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb max_width=\u00bb64px\u00bb max_height=\u00bb64px\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbeb254ae5-cb97-4f48-8335-7aee66a763fe\u00bb header_4_text_color=\u00bbgcid-primary-color\u00bb text_orientation=\u00bbcenter\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22header_4_text_color%22%93}\u00bb]<\/p>\n

PCSK9 y aterosclerosis<\/span><\/h4>\n

[\/et_pb_text][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb31px||||false|false\u00bb link_option_url=\u00bbhttps:\/\/r3i.org\/es\/folleto-pcsk9-y-aterosclerosis\/\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

M\u00e1s informaci\u00f3n…<\/span><\/p>\n

[\/et_pb_text][et_pb_button button_url=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2024\/12\/PCSK9__Atherosclerosis_booklet.pdf\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbDescargar folleto (PDF)\u00bb button_alignment=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb|||0px|false|false\u00bb custom_margin_tablet=\u00bb|||0px|false|false\u00bb custom_margin_phone=\u00bb|||0px|false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

Folletos de R3iLos folletos R3i proporcionan valiosos conocimientos e informaci\u00f3n basada en pruebas para educar a los profesionales de la salud sobre el riesgo vascular residual y las terapias emergentes, como los tratamientos dirigidos a la PCSK9 y los agonistas SPPARM\u03b1. Mediante la difusi\u00f3n de los resultados de la investigaci\u00f3n, los resultados de los ensayos […]<\/p>\n","protected":false},"author":258497325,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_crdt_document":"","jetpack_post_was_ever_published":true,"footnotes":""},"class_list":["post-252640","page","type-page","status-publish","hentry"],"yoast_head":"\nFolletos - R3I<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/r3i.org\/es\/folletos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Folletos - R3I\" \/>\n<meta property=\"og:description\" content=\"Folletos de R3iLos folletos R3i proporcionan valiosos conocimientos e informaci\u00f3n basada en pruebas para educar a los profesionales de la salud sobre el riesgo vascular residual y las terapias emergentes, como los tratamientos dirigidos a la PCSK9 y los agonistas SPPARM\u03b1. Mediante la difusi\u00f3n de los resultados de la investigaci\u00f3n, los resultados de los ensayos […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/r3i.org\/es\/folletos\/\" \/>\n<meta property=\"og:site_name\" content=\"R3I\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-24T14:42:26+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"15 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/folletos\\\/\",\"url\":\"https:\\\/\\\/r3i.org\\\/es\\\/folletos\\\/\",\"name\":\"Folletos - R3I\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#website\"},\"datePublished\":\"2024-12-07T13:54:03+00:00\",\"dateModified\":\"2025-10-24T14:42:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/folletos\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/r3i.org\\\/es\\\/folletos\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/folletos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/r3i.org\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Folletos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/r3i.org\\\/es\\\/\",\"name\":\"R3I\",\"description\":\"Residual Risk Reduction Initiative\",\"publisher\":{\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/r3i.org\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#organization\",\"name\":\"R3I\",\"url\":\"https:\\\/\\\/r3i.org\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/r3i.org\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/r3i-logo-transp-1.png?fit=1601%2C834&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/r3i.org\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/r3i-logo-transp-1.png?fit=1601%2C834&ssl=1\",\"width\":1601,\"height\":834,\"caption\":\"R3I\"},\"image\":{\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Folletos - R3I","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/r3i.org\/es\/folletos\/","og_locale":"es_ES","og_type":"article","og_title":"Folletos - R3I","og_description":"Folletos de R3iLos folletos R3i proporcionan valiosos conocimientos e informaci\u00f3n basada en pruebas para educar a los profesionales de la salud sobre el riesgo vascular residual y las terapias emergentes, como los tratamientos dirigidos a la PCSK9 y los agonistas SPPARM\u03b1. Mediante la difusi\u00f3n de los resultados de la investigaci\u00f3n, los resultados de los ensayos […]","og_url":"https:\/\/r3i.org\/es\/folletos\/","og_site_name":"R3I","article_modified_time":"2025-10-24T14:42:26+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"15 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/r3i.org\/es\/folletos\/","url":"https:\/\/r3i.org\/es\/folletos\/","name":"Folletos - R3I","isPartOf":{"@id":"https:\/\/r3i.org\/es\/#website"},"datePublished":"2024-12-07T13:54:03+00:00","dateModified":"2025-10-24T14:42:26+00:00","breadcrumb":{"@id":"https:\/\/r3i.org\/es\/folletos\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/r3i.org\/es\/folletos\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/r3i.org\/es\/folletos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/r3i.org\/es\/"},{"@type":"ListItem","position":2,"name":"Folletos"}]},{"@type":"WebSite","@id":"https:\/\/r3i.org\/es\/#website","url":"https:\/\/r3i.org\/es\/","name":"R3I","description":"Residual Risk Reduction Initiative","publisher":{"@id":"https:\/\/r3i.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/r3i.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/r3i.org\/es\/#organization","name":"R3I","url":"https:\/\/r3i.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/r3i.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/r3i.org\/wp-content\/uploads\/2024\/11\/r3i-logo-transp-1.png?fit=1601%2C834&ssl=1","contentUrl":"https:\/\/i0.wp.com\/r3i.org\/wp-content\/uploads\/2024\/11\/r3i-logo-transp-1.png?fit=1601%2C834&ssl=1","width":1601,"height":834,"caption":"R3I"},"image":{"@id":"https:\/\/r3i.org\/es\/#\/schema\/logo\/image\/"}}]}},"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/Pgbfv2-13IQ","jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/pages\/252640","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/users\/258497325"}],"replies":[{"embeddable":true,"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/comments?post=252640"}],"version-history":[{"count":15,"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/pages\/252640\/revisions"}],"predecessor-version":[{"id":256104,"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/pages\/252640\/revisions\/256104"}],"wp:attachment":[{"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/media?parent=252640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}